Direct Conversion Through Trans-Differentiation: Efficacy and Safety

被引:14
|
作者
Prasad, Ankshita [1 ]
Teh, Daniel Boon Loong [2 ]
Jahan, Fathima R. Shah [3 ]
Manivannan, Janani [3 ]
Chua, Soo Min [2 ]
All, Angelo H. [3 ,4 ,5 ]
机构
[1] Natl Univ Singapore, Dept Biomed Engn, Singapore, Singapore
[2] Natl Univ Singapore, Singapore Inst Neurotechnol, Singapore, Singapore
[3] Natl Univ Singapore, Dept Orthopaed Surg, 1E Kent Ridge Rd,NUHS Tower Block,Level 11, Singapore 119228, Singapore
[4] Johns Hopkins Sch Med, Dept Biomed Engn, Baltimore, MD USA
[5] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA
关键词
transdifferentiation; induced pluripotent; differentiation; comprehensive review; PLURIPOTENT STEM-CELLS; FUNCTIONAL-NEURONS; MOUSE FIBROBLASTS; TRANSCRIPTION FACTORS; CELLULAR SENESCENCE; LINEAGE CONVERSION; SMALL MOLECULES; SOMATIC-CELLS; P53; CARDIOMYOCYTES;
D O I
10.1089/scd.2016.0174
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Direct conversion through transdifferentiation is a promising cell reprogramming approach that induces a cell lineage conversion among adult cells without passing through an intermediate pluripotent phase. However, there is a need to critically evaluate the efficacy and safety of direct conversion to establish its feasibility as a clinically viable cell reprogramming technique. This review article aims to delineate some critical constraints of direct conversion as a cellular reprogramming approach. We report the most important challenges of lineage reprogramming through direct conversion and divide them into two major sections. The first section explores the obstacles that limit the efficiency of the direct conversion process. In this study, we discuss challenges such as lack of understanding of molecular mechanism and transcriptional control of direct conversion, low proliferative capacity of converted cells, and senescence and apoptosis as critical barriers of direct conversion. The second section focuses on addressing concerns of safety of directly converted cells. We describe issues of transgene load and epigenetic memory retention along with the constraints of currently available validation tools to characterize reprogrammed cells. Each issue mentioned above is evaluated in view of their origin, implications, progress made toward their resolution and scope for development of new strategies to address the constraints of the present technique.
引用
收藏
页码:154 / 165
页数:12
相关论文
共 50 条
  • [31] NXL-004: A novel trans-differentiation therapy for glioblastoma treatment
    Chen, Yuchen
    Chen, Ming
    Kuo, Tsangchih
    Zhou, Kai
    Jin, Sen
    Liu, Meng
    Chen, Ming Moon
    Chen, Shiyuan
    Li, Xuetao
    Jiang, Zuoyu
    Pu, Liting
    Chen, Adalia
    Gao, Xiang
    Xu, Jie
    Sheng, Jian
    Huang, Yulun
    Chen, Gong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [32] Trans-differentiation of somatic cells into insulin secreting cells by epigenetic engineering
    Naqvi, Raza A.
    Zhang, Wenjun
    Isidan, Abdulkadir
    Lashmet, Matthew
    Fridell, Jonathan A.
    Li, Ping
    Ekser, Burcin
    XENOTRANSPLANTATION, 2019, 26 (05)
  • [33] Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation
    Somerville, Tim D. D.
    Biffi, Giulia
    Dassler-Plenker, Juliane
    Hur, Stella K.
    He, Xue-Yan
    Vance, Krysten E.
    Miyabayashi, Koji
    Xu, Yali
    Maia-Silva, Diogo
    Klingbeil, Olaf
    Demerdash, Osama E.
    Preall, Jonathan B.
    Hollingsworth, Michael A.
    Egeblad, Mikala
    Tuveson, David A.
    Vakoc, Christopher R.
    ELIFE, 2020, 9
  • [34] In situ trans-differentiation therapy effectively terminates the growth and recurrence of glioblastoma
    Zhao, Huihui
    Li, Zhaozhong
    Zhang, Xiaohui
    Zhao, Congjian
    Zhu, Zhao
    Liu, Yueguang
    CANCER RESEARCH, 2024, 84 (06)
  • [35] Adult stem cells and their trans-differentiation potential—perspectives and therapeutic applications
    Sabine Hombach-Klonisch
    Soumya Panigrahi
    Iran Rashedi
    Anja Seifert
    Esteban Alberti
    Paola Pocar
    Maciej Kurpisz
    Klaus Schulze-Osthoff
    Andrzej Mackiewicz
    Marek Los
    Journal of Molecular Medicine, 2008, 86 : 1301 - 1314
  • [36] Haemophilus influenzae causes cellular trans-differentiation in human bronchial epithelia
    Gloeckner, Michael
    Marwitz, Sebastian
    Rohmann, Kristina
    Watz, Henrik
    Nitschkowski, Doerte
    Rupp, Jan
    Dalhoff, Klaus
    Goldmann, Torsten
    Droemann, Daniel
    INNATE IMMUNITY, 2021, 27 (03) : 251 - 259
  • [37] A transient disruption of fibroblastic transcriptional regulatory network facilitates trans-differentiation
    Tomaru, Yasuhiro
    Hasegawa, Ryota
    Suzuki, Takahiro
    Sato, Taiji
    Kubosaki, Atsutaka
    Suzuki, Masanori
    Kawaji, Hideya
    Forrest, Alistair R. R.
    Hayashizaki, Yoshihide
    Shin, Jay W.
    Suzuki, Harukazu
    NUCLEIC ACIDS RESEARCH, 2014, 42 (14) : 8905 - 8913
  • [38] The De-, Re-, and trans-differentiation of β-cells: Regulation and function
    Zhang, Jingjing
    Liu, Feng
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2020, 103 : 68 - 75
  • [39] Dexamethasone Induces Mesenchymal Trans-differentiation and Promotes Hallmarks of Cancer in Glioblastoma
    Zinn, Pascal O.
    Luedi, Markus M.
    Singh, Sanjay K.
    Mosley, Jennifer
    Hassan, Islam
    Hatami, Masumeh
    Gumin, Joy
    Andereggen, Lukas
    Sulman, Erik P.
    Lang, Frederick F.
    Stueber, Frank
    Fuller, Gregory N.
    Colen, Rivka R.
    NEUROSURGERY, 2017, 64 : 260 - 261
  • [40] Acinar to ductal cell trans-differentiation: A prelude to dysplasia and pancreatic ductal adenocarcinoma
    Parte, Seema
    Nimmakayala, Rama Krishna
    Batra, Surinder K.
    Ponnusamy, Moorthy P.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2022, 1877 (01):